We conducted an investigation of the in vitro toxic and genotoxic properties of Cleome amblyocarpa Barr. and Murb, which is an important medicinal plant in Tunisia where it is widely used against colic and diabetes. In this study we investigated methanol extracts of the whole plant with the neutral red uptake test for assessing its in vitro toxicity and the alkaline comet assay for genotoxicity. It appeared that the extract was not genotoxic in subtoxic concentrations. However, the neutral red uptake test revealed that it was highly toxic and therefore some caution, especially regarding dosage and frequency of use, is warranted.
Introduction
As part of our ongoing effort to establish the safety of herbal products we conducted a preliminary investigation of the in vitro toxic and genotoxic properties of Cleome amblyocarpa, which is an important Tunisian medicinal plant. Cleome species are generally used in folk medicine as stomachics, rubefacients and in the treatment of scabies, rheumatic fever and inflammation (Boulos, 1983 (Boulos, , 1999 Chopra et al., 1972; Ghazanfar, 1994) . C. amblyocarpa is commonly used as a bechic and a sedative and is also used mixed with Juniperus phoenicea to ease pain, Hammada scoparia for headaches, and Artemisia herba alba for nausea, gastralgia, vomiting and colic. It is known that the plant causes nervous disorders in animals (Le Floch, 1983 ). This plant is of particular importance in Tunisia where it is used against colic and diabetes.
We here report on the neutral red uptake (NRU) test and the alkaline comet assay for in vitro toxicity and genotoxicity evaluation. Both tests are well known and considered important tools in (geno)toxicity testing.
Materials and methods
C. amblyocarpa was collected in 2009 in Kerker (Tunisian centre). A voucher specimen (C.A.02.02) was deposited in the biological laboratory of the Faculty of Pharmacy of Monastir. Methanol extracts were prepared according to standard methods (Edziri et al., 2012) and subjected to the neutral red uptake (NRU) cytotoxicity assay and the alkaline comet assay to assess genotoxicity. Tests were performed as described elsewhere (Verschaeve et al., in press ). Statistical analysis between control and exposed cells was performed with the non-parametric MannWhitney U test.
Results and discussion
Tests were performed in C3A cells that are derived from HepG2 human carcinoma cells. This cell line was chosen as the cells have the essential structural, biochemical and growth features of normal human liver cells and have conserved both phase I and phase II metabolic capacities (Kelly, 1994) . We have conducted several NRU tests using different concentration ranges as shown in Fig. 1 . It can be seen that the results indicate that the NI 50 (concentration inducing a 50% lethality) is approximately 5 μg/ml. The extract is therefore even more toxic (×10) than our positive control (SDS) where the NI 50 was found to be 57.7 μg/ml. It is also much more toxic than some other commonly used medicinal plants and commercial plant preparations (e.g., Ndhlala et al., 2010; Edziri et al., South African Journal of Botany 84 (2013) Contents lists available at SciVerse ScienceDirect
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2011). C. amblyocarpa should therefore be considered as a potent in vitro toxic compound. Use of this plant in medicinal preparations should for this reason, especially if confirmed by in vivo investigations, be subjected to strict conditions, in particular regarding dosage. Strong in vivo toxicity of this plant was already reported. It causes fever, rapid pulse, dilation of pupils, hot and dry flushed skin, headache, dry mouth, and difficulty in swallowing, burning of the throat, hallucinations, and convulsions (Sharawy and Alshammari, 2009 ). We tested 0-1 μg/ml concentrations of the plant extract with the alkaline comet assay that detects single and double strand DNA breaks as well as alkali labile sites. These concentrations were based on the results of the NRU test and were chosen in such a way that viability was always higher than 70%. Table 1 clearly shows that the percentage of DNA in the 'comet tail', which is indicative of the degree of DNA damage, was not significantly different from that of the unexposed control cells (mean and median values were almost identical in all cases). Regarding the alkaline comet assay it should be noted that the % DNA in the comet tail can theoretically be between 0% and 100% (apoptotic) with most cells having low % tail DNA in the control cultures and a shift to more cells with more substantial DNA damage for increasing concentrations of a genotoxic compound. Although most cells have more or less similar (and low) DNA damage levels some have excess damage (also in the unexposed controls). Inclusion of these (up to 70% damage) results in high standard deviations which are therefore not unusual and normal.
Conclusions
In conclusion our data clearly show that the C. amblyocarpa extract is toxic but does not show any genotoxicity based on the results of the alkaline comet assay.
Because of its widespread use and high toxicity further studies should be encouraged. 
